nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—Levorphanol—Estrone—prostate cancer	0.216	0.569	CrCrCtD
Hydrocodone—Levorphanol—Estradiol—prostate cancer	0.164	0.431	CrCrCtD
Hydrocodone—CYP3A4—prostate cancer	0.142	1	CbGaD
Hydrocodone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0431	0.154	CbGbCtD
Hydrocodone—CYP2D6—Bicalutamide—prostate cancer	0.0356	0.128	CbGbCtD
Hydrocodone—CYP2D6—Abiraterone—prostate cancer	0.0295	0.106	CbGbCtD
Hydrocodone—CYP3A4—Bicalutamide—prostate cancer	0.0227	0.0811	CbGbCtD
Hydrocodone—CYP3A4—Estramustine—prostate cancer	0.0211	0.0754	CbGbCtD
Hydrocodone—CYP3A4—Abiraterone—prostate cancer	0.0188	0.0672	CbGbCtD
Hydrocodone—CYP3A4—Flutamide—prostate cancer	0.0188	0.0672	CbGbCtD
Hydrocodone—CYP3A4—Cabazitaxel—prostate cancer	0.0139	0.0497	CbGbCtD
Hydrocodone—CYP3A4—Estrone—prostate cancer	0.0136	0.0486	CbGbCtD
Hydrocodone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0121	0.0433	CbGbCtD
Hydrocodone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00888	0.0318	CbGbCtD
Hydrocodone—CYP3A4—Mitoxantrone—prostate cancer	0.00807	0.0289	CbGbCtD
Hydrocodone—CYP3A4—Estradiol—prostate cancer	0.0078	0.0279	CbGbCtD
Hydrocodone—CYP3A4—Prednisone—prostate cancer	0.0067	0.024	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—prostate cancer	0.00546	0.0196	CbGbCtD
Hydrocodone—CYP3A4—Etoposide—prostate cancer	0.00509	0.0182	CbGbCtD
Hydrocodone—CYP3A4—Docetaxel—prostate cancer	0.00466	0.0167	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—prostate cancer	0.00347	0.0124	CbGbCtD
Hydrocodone—Dextromethorphan—PGRMC1—prostate cancer	0.000901	0.22	CrCbGaD
Hydrocodone—Morphine—UGT2B15—prostate cancer	0.00065	0.159	CrCbGaD
Hydrocodone—Naloxone—TLR4—prostate cancer	0.000506	0.124	CrCbGaD
Hydrocodone—Galantamine—ACHE—prostate cancer	0.000248	0.0606	CrCbGaD
Hydrocodone—Codeine—SLC22A1—prostate cancer	0.000216	0.0529	CrCbGaD
Hydrocodone—Oxycodone—CYP3A5—prostate cancer	0.000183	0.0447	CrCbGaD
Hydrocodone—Codeine—CYP3A5—prostate cancer	0.000175	0.0427	CrCbGaD
Hydrocodone—Naloxone—ESR1—prostate cancer	0.000142	0.0347	CrCbGaD
Hydrocodone—Dextromethorphan—CYP3A5—prostate cancer	0.000119	0.029	CrCbGaD
Hydrocodone—Dihydrocodeine—CYP3A4—prostate cancer	0.000113	0.0277	CrCbGaD
Hydrocodone—Oxymorphone—CYP3A4—prostate cancer	9.93e-05	0.0243	CrCbGaD
Hydrocodone—Ethylmorphine—CYP3A4—prostate cancer	9.49e-05	0.0232	CrCbGaD
Hydrocodone—Migraine—Doxorubicin—prostate cancer	9.27e-05	0.000665	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—prostate cancer	9.27e-05	0.000665	CcSEcCtD
Hydrocodone—Hypokalaemia—Epirubicin—prostate cancer	9.26e-05	0.000665	CcSEcCtD
Hydrocodone—Fatigue—Mitoxantrone—prostate cancer	9.25e-05	0.000664	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	9.24e-05	0.000663	CcSEcCtD
Hydrocodone—Vomiting—Goserelin—prostate cancer	9.23e-05	0.000663	CcSEcCtD
Hydrocodone—Constipation—Mitoxantrone—prostate cancer	9.17e-05	0.000658	CcSEcCtD
Hydrocodone—Angiopathy—Capecitabine—prostate cancer	9.17e-05	0.000658	CcSEcCtD
Hydrocodone—Rash—Goserelin—prostate cancer	9.15e-05	0.000657	CcSEcCtD
Hydrocodone—Dermatitis—Goserelin—prostate cancer	9.15e-05	0.000657	CcSEcCtD
Hydrocodone—Vomiting—Conjugated Estrogens—prostate cancer	9.14e-05	0.000656	CcSEcCtD
Hydrocodone—Mental disorder—Docetaxel—prostate cancer	9.14e-05	0.000656	CcSEcCtD
Hydrocodone—Mediastinal disorder—Capecitabine—prostate cancer	9.11e-05	0.000654	CcSEcCtD
Hydrocodone—Body temperature increased—Estradiol—prostate cancer	9.1e-05	0.000653	CcSEcCtD
Hydrocodone—Abdominal pain—Estradiol—prostate cancer	9.1e-05	0.000653	CcSEcCtD
Hydrocodone—Headache—Goserelin—prostate cancer	9.1e-05	0.000653	CcSEcCtD
Hydrocodone—Malnutrition—Docetaxel—prostate cancer	9.08e-05	0.000652	CcSEcCtD
Hydrocodone—Rash—Conjugated Estrogens—prostate cancer	9.07e-05	0.000651	CcSEcCtD
Hydrocodone—Dermatitis—Conjugated Estrogens—prostate cancer	9.06e-05	0.00065	CcSEcCtD
Hydrocodone—Headache—Conjugated Estrogens—prostate cancer	9.01e-05	0.000647	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—prostate cancer	8.92e-05	0.00064	CcSEcCtD
Hydrocodone—Mental disorder—Capecitabine—prostate cancer	8.85e-05	0.000635	CcSEcCtD
Hydrocodone—Connective tissue disorder—Prednisone—prostate cancer	8.84e-05	0.000635	CcSEcCtD
Hydrocodone—Malnutrition—Capecitabine—prostate cancer	8.8e-05	0.000631	CcSEcCtD
Hydrocodone—Back pain—Docetaxel—prostate cancer	8.79e-05	0.000631	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Mitoxantrone—prostate cancer	8.77e-05	0.00063	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—prostate cancer	8.75e-05	0.000629	CcSEcCtD
Hydrocodone—Thrombocytopenia—Etoposide—prostate cancer	8.73e-05	0.000627	CcSEcCtD
Hydrocodone—Muscle spasms—Docetaxel—prostate cancer	8.73e-05	0.000627	CcSEcCtD
Hydrocodone—Skin disorder—Etoposide—prostate cancer	8.67e-05	0.000622	CcSEcCtD
Hydrocodone—Nausea—Goserelin—prostate cancer	8.62e-05	0.000619	CcSEcCtD
Hydrocodone—Hyperhidrosis—Etoposide—prostate cancer	8.62e-05	0.000619	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—prostate cancer	8.57e-05	0.000615	CcSEcCtD
Hydrocodone—Nausea—Conjugated Estrogens—prostate cancer	8.54e-05	0.000613	CcSEcCtD
Hydrocodone—Back pain—Capecitabine—prostate cancer	8.51e-05	0.000611	CcSEcCtD
Hydrocodone—Hypersensitivity—Estradiol—prostate cancer	8.48e-05	0.000609	CcSEcCtD
Hydrocodone—Abdominal pain—Mitoxantrone—prostate cancer	8.48e-05	0.000609	CcSEcCtD
Hydrocodone—Body temperature increased—Mitoxantrone—prostate cancer	8.48e-05	0.000609	CcSEcCtD
Hydrocodone—Muscle spasms—Capecitabine—prostate cancer	8.46e-05	0.000607	CcSEcCtD
Hydrocodone—Hypotension—Etoposide—prostate cancer	8.34e-05	0.000598	CcSEcCtD
Hydrocodone—Asthenia—Estradiol—prostate cancer	8.26e-05	0.000593	CcSEcCtD
Hydrocodone—Tremor—Capecitabine—prostate cancer	8.24e-05	0.000592	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Epirubicin—prostate cancer	8.17e-05	0.000587	CcSEcCtD
Hydrocodone—Angiopathy—Prednisone—prostate cancer	8.17e-05	0.000586	CcSEcCtD
Hydrocodone—Dextromethorphan—CYP2E1—prostate cancer	8.15e-05	0.0199	CrCbGaD
Hydrocodone—Pruritus—Estradiol—prostate cancer	8.14e-05	0.000585	CcSEcCtD
Hydrocodone—Dextromethorphan—CYP2C19—prostate cancer	8.07e-05	0.0197	CrCbGaD
Hydrocodone—Paraesthesia—Etoposide—prostate cancer	8.01e-05	0.000575	CcSEcCtD
Hydrocodone—Dyspnoea—Etoposide—prostate cancer	7.95e-05	0.000571	CcSEcCtD
Hydrocodone—Somnolence—Etoposide—prostate cancer	7.93e-05	0.000569	CcSEcCtD
Hydrocodone—Cough—Docetaxel—prostate cancer	7.93e-05	0.000569	CcSEcCtD
Hydrocodone—Oxycodone—CYP3A4—prostate cancer	7.92e-05	0.0194	CrCbGaD
Hydrocodone—Hypersensitivity—Mitoxantrone—prostate cancer	7.9e-05	0.000567	CcSEcCtD
Hydrocodone—Mental disorder—Prednisone—prostate cancer	7.88e-05	0.000566	CcSEcCtD
Hydrocodone—Convulsion—Docetaxel—prostate cancer	7.87e-05	0.000565	CcSEcCtD
Hydrocodone—Drowsiness—Epirubicin—prostate cancer	7.84e-05	0.000563	CcSEcCtD
Hydrocodone—Malnutrition—Prednisone—prostate cancer	7.83e-05	0.000562	CcSEcCtD
Hydrocodone—Arthralgia—Docetaxel—prostate cancer	7.73e-05	0.000555	CcSEcCtD
Hydrocodone—Myalgia—Docetaxel—prostate cancer	7.73e-05	0.000555	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Etoposide—prostate cancer	7.7e-05	0.000553	CcSEcCtD
Hydrocodone—Asthenia—Mitoxantrone—prostate cancer	7.69e-05	0.000552	CcSEcCtD
Hydrocodone—Fatigue—Etoposide—prostate cancer	7.69e-05	0.000552	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	7.68e-05	0.000551	CcSEcCtD
Hydrocodone—Cough—Capecitabine—prostate cancer	7.67e-05	0.000551	CcSEcCtD
Hydrocodone—Constipation—Etoposide—prostate cancer	7.63e-05	0.000548	CcSEcCtD
Hydrocodone—Urinary tract infection—Epirubicin—prostate cancer	7.62e-05	0.000547	CcSEcCtD
Hydrocodone—Dizziness—Estradiol—prostate cancer	7.61e-05	0.000546	CcSEcCtD
Hydrocodone—Dry mouth—Docetaxel—prostate cancer	7.56e-05	0.000543	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—prostate cancer	7.56e-05	0.000543	CcSEcCtD
Hydrocodone—Codeine—CYP3A4—prostate cancer	7.56e-05	0.0185	CrCbGaD
Hydrocodone—Arthralgia—Capecitabine—prostate cancer	7.49e-05	0.000538	CcSEcCtD
Hydrocodone—Myalgia—Capecitabine—prostate cancer	7.49e-05	0.000538	CcSEcCtD
Hydrocodone—Anxiety—Capecitabine—prostate cancer	7.46e-05	0.000536	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	7.44e-05	0.000534	CcSEcCtD
Hydrocodone—Dry mouth—Capecitabine—prostate cancer	7.32e-05	0.000526	CcSEcCtD
Hydrocodone—Vomiting—Estradiol—prostate cancer	7.32e-05	0.000525	CcSEcCtD
Hydrocodone—Agranulocytosis—Epirubicin—prostate cancer	7.32e-05	0.000525	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Etoposide—prostate cancer	7.29e-05	0.000524	CcSEcCtD
Hydrocodone—Nervous system disorder—Docetaxel—prostate cancer	7.27e-05	0.000522	CcSEcCtD
Hydrocodone—Thrombocytopenia—Docetaxel—prostate cancer	7.26e-05	0.000521	CcSEcCtD
Hydrocodone—Rash—Estradiol—prostate cancer	7.26e-05	0.000521	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—prostate cancer	7.25e-05	0.000521	CcSEcCtD
Hydrocodone—Dermatitis—Estradiol—prostate cancer	7.25e-05	0.000521	CcSEcCtD
Hydrocodone—Naloxone—CYP3A4—prostate cancer	7.24e-05	0.0177	CrCbGaD
Hydrocodone—Headache—Estradiol—prostate cancer	7.21e-05	0.000518	CcSEcCtD
Hydrocodone—Skin disorder—Docetaxel—prostate cancer	7.2e-05	0.000517	CcSEcCtD
Hydrocodone—Hydromorphone—CYP3A4—prostate cancer	7.19e-05	0.0176	CrCbGaD
Hydrocodone—Abdominal pain—Etoposide—prostate cancer	7.05e-05	0.000506	CcSEcCtD
Hydrocodone—Body temperature increased—Etoposide—prostate cancer	7.05e-05	0.000506	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—prostate cancer	7.05e-05	0.000506	CcSEcCtD
Hydrocodone—Nervous system disorder—Capecitabine—prostate cancer	7.04e-05	0.000505	CcSEcCtD
Hydrocodone—Thrombocytopenia—Capecitabine—prostate cancer	7.03e-05	0.000505	CcSEcCtD
Hydrocodone—Skin disorder—Capecitabine—prostate cancer	6.97e-05	0.000501	CcSEcCtD
Hydrocodone—Hyperhidrosis—Capecitabine—prostate cancer	6.94e-05	0.000498	CcSEcCtD
Hydrocodone—Oedema peripheral—Epirubicin—prostate cancer	6.93e-05	0.000498	CcSEcCtD
Hydrocodone—Hypotension—Docetaxel—prostate cancer	6.93e-05	0.000497	CcSEcCtD
Hydrocodone—Connective tissue disorder—Epirubicin—prostate cancer	6.92e-05	0.000497	CcSEcCtD
Hydrocodone—Galantamine—CYP3A4—prostate cancer	6.86e-05	0.0168	CrCbGaD
Hydrocodone—Nausea—Estradiol—prostate cancer	6.84e-05	0.000491	CcSEcCtD
Hydrocodone—Vomiting—Mitoxantrone—prostate cancer	6.82e-05	0.00049	CcSEcCtD
Hydrocodone—Convulsion—Prednisone—prostate cancer	6.79e-05	0.000487	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—prostate cancer	6.77e-05	0.000486	CcSEcCtD
Hydrocodone—Rash—Mitoxantrone—prostate cancer	6.76e-05	0.000485	CcSEcCtD
Hydrocodone—Dermatitis—Mitoxantrone—prostate cancer	6.76e-05	0.000485	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Docetaxel—prostate cancer	6.75e-05	0.000485	CcSEcCtD
Hydrocodone—Headache—Mitoxantrone—prostate cancer	6.72e-05	0.000482	CcSEcCtD
Hydrocodone—Hypotension—Capecitabine—prostate cancer	6.71e-05	0.000482	CcSEcCtD
Hydrocodone—Insomnia—Docetaxel—prostate cancer	6.71e-05	0.000481	CcSEcCtD
Hydrocodone—Myalgia—Prednisone—prostate cancer	6.67e-05	0.000479	CcSEcCtD
Hydrocodone—Arthralgia—Prednisone—prostate cancer	6.67e-05	0.000479	CcSEcCtD
Hydrocodone—Paraesthesia—Docetaxel—prostate cancer	6.66e-05	0.000478	CcSEcCtD
Hydrocodone—Anxiety—Prednisone—prostate cancer	6.65e-05	0.000477	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	6.62e-05	0.000476	CcSEcCtD
Hydrocodone—Dyspnoea—Docetaxel—prostate cancer	6.61e-05	0.000475	CcSEcCtD
Hydrocodone—Somnolence—Docetaxel—prostate cancer	6.59e-05	0.000473	CcSEcCtD
Hydrocodone—Hypersensitivity—Etoposide—prostate cancer	6.57e-05	0.000472	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Capecitabine—prostate cancer	6.54e-05	0.000469	CcSEcCtD
Hydrocodone—Insomnia—Capecitabine—prostate cancer	6.49e-05	0.000466	CcSEcCtD
Hydrocodone—Paraesthesia—Capecitabine—prostate cancer	6.45e-05	0.000463	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—prostate cancer	6.42e-05	0.000461	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Docetaxel—prostate cancer	6.4e-05	0.00046	CcSEcCtD
Hydrocodone—Asthenia—Etoposide—prostate cancer	6.4e-05	0.000459	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—prostate cancer	6.4e-05	0.000459	CcSEcCtD
Hydrocodone—Dyspnoea—Capecitabine—prostate cancer	6.4e-05	0.000459	CcSEcCtD
Hydrocodone—Fatigue—Docetaxel—prostate cancer	6.39e-05	0.000459	CcSEcCtD
Hydrocodone—Angiopathy—Epirubicin—prostate cancer	6.39e-05	0.000458	CcSEcCtD
Hydrocodone—Nausea—Mitoxantrone—prostate cancer	6.37e-05	0.000457	CcSEcCtD
Hydrocodone—Mediastinal disorder—Epirubicin—prostate cancer	6.34e-05	0.000455	CcSEcCtD
Hydrocodone—Constipation—Docetaxel—prostate cancer	6.34e-05	0.000455	CcSEcCtD
Hydrocodone—Pruritus—Etoposide—prostate cancer	6.31e-05	0.000453	CcSEcCtD
Hydrocodone—Nervous system disorder—Prednisone—prostate cancer	6.27e-05	0.00045	CcSEcCtD
Hydrocodone—Skin disorder—Prednisone—prostate cancer	6.21e-05	0.000446	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Capecitabine—prostate cancer	6.2e-05	0.000445	CcSEcCtD
Hydrocodone—Fatigue—Capecitabine—prostate cancer	6.19e-05	0.000444	CcSEcCtD
Hydrocodone—Hyperhidrosis—Prednisone—prostate cancer	6.18e-05	0.000444	CcSEcCtD
Hydrocodone—Mental disorder—Epirubicin—prostate cancer	6.17e-05	0.000443	CcSEcCtD
Hydrocodone—Constipation—Capecitabine—prostate cancer	6.14e-05	0.000441	CcSEcCtD
Hydrocodone—Malnutrition—Epirubicin—prostate cancer	6.13e-05	0.00044	CcSEcCtD
Hydrocodone—Morphine—CYP3A4—prostate cancer	6.12e-05	0.015	CrCbGaD
Hydrocodone—Gastrointestinal pain—Docetaxel—prostate cancer	6.06e-05	0.000435	CcSEcCtD
Hydrocodone—Back pain—Epirubicin—prostate cancer	5.93e-05	0.000425	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—prostate cancer	5.91e-05	0.000424	CcSEcCtD
Hydrocodone—Dizziness—Etoposide—prostate cancer	5.9e-05	0.000424	CcSEcCtD
Hydrocodone—Muscle spasms—Epirubicin—prostate cancer	5.89e-05	0.000423	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Capecitabine—prostate cancer	5.87e-05	0.000421	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—prostate cancer	5.87e-05	0.000421	CcSEcCtD
Hydrocodone—Abdominal pain—Docetaxel—prostate cancer	5.86e-05	0.000421	CcSEcCtD
Hydrocodone—Body temperature increased—Docetaxel—prostate cancer	5.86e-05	0.000421	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Prednisone—prostate cancer	5.83e-05	0.000418	CcSEcCtD
Hydrocodone—Insomnia—Prednisone—prostate cancer	5.78e-05	0.000415	CcSEcCtD
Hydrocodone—Paraesthesia—Prednisone—prostate cancer	5.74e-05	0.000412	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—prostate cancer	5.71e-05	0.00041	CcSEcCtD
Hydrocodone—Abdominal pain—Capecitabine—prostate cancer	5.67e-05	0.000407	CcSEcCtD
Hydrocodone—Body temperature increased—Capecitabine—prostate cancer	5.67e-05	0.000407	CcSEcCtD
Hydrocodone—Vomiting—Etoposide—prostate cancer	5.67e-05	0.000407	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—prostate cancer	5.67e-05	0.000407	CcSEcCtD
Hydrocodone—Rash—Etoposide—prostate cancer	5.62e-05	0.000404	CcSEcCtD
Hydrocodone—Dermatitis—Etoposide—prostate cancer	5.62e-05	0.000403	CcSEcCtD
Hydrocodone—Headache—Etoposide—prostate cancer	5.59e-05	0.000401	CcSEcCtD
Hydrocodone—Fatigue—Prednisone—prostate cancer	5.51e-05	0.000396	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—prostate cancer	5.48e-05	0.000394	CcSEcCtD
Hydrocodone—Constipation—Prednisone—prostate cancer	5.47e-05	0.000393	CcSEcCtD
Hydrocodone—Hypersensitivity—Docetaxel—prostate cancer	5.46e-05	0.000392	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—prostate cancer	5.45e-05	0.000391	CcSEcCtD
Hydrocodone—Cough—Epirubicin—prostate cancer	5.35e-05	0.000384	CcSEcCtD
Hydrocodone—Asthenia—Docetaxel—prostate cancer	5.32e-05	0.000382	CcSEcCtD
Hydrocodone—Convulsion—Epirubicin—prostate cancer	5.31e-05	0.000381	CcSEcCtD
Hydrocodone—Nausea—Etoposide—prostate cancer	5.3e-05	0.00038	CcSEcCtD
Hydrocodone—Hypersensitivity—Capecitabine—prostate cancer	5.29e-05	0.00038	CcSEcCtD
Hydrocodone—Pruritus—Docetaxel—prostate cancer	5.25e-05	0.000377	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Prednisone—prostate cancer	5.23e-05	0.000375	CcSEcCtD
Hydrocodone—Arthralgia—Epirubicin—prostate cancer	5.22e-05	0.000374	CcSEcCtD
Hydrocodone—Myalgia—Epirubicin—prostate cancer	5.22e-05	0.000374	CcSEcCtD
Hydrocodone—Anxiety—Epirubicin—prostate cancer	5.2e-05	0.000373	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.18e-05	0.000372	CcSEcCtD
Hydrocodone—Asthenia—Capecitabine—prostate cancer	5.15e-05	0.00037	CcSEcCtD
Hydrocodone—Dextromethorphan—CYP3A4—prostate cancer	5.13e-05	0.0126	CrCbGaD
Hydrocodone—Dry mouth—Epirubicin—prostate cancer	5.1e-05	0.000366	CcSEcCtD
Hydrocodone—Pruritus—Capecitabine—prostate cancer	5.08e-05	0.000365	CcSEcCtD
Hydrocodone—Abdominal pain—Prednisone—prostate cancer	5.05e-05	0.000363	CcSEcCtD
Hydrocodone—Body temperature increased—Prednisone—prostate cancer	5.05e-05	0.000363	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—prostate cancer	4.95e-05	0.000355	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—prostate cancer	4.91e-05	0.000353	CcSEcCtD
Hydrocodone—Nervous system disorder—Epirubicin—prostate cancer	4.9e-05	0.000352	CcSEcCtD
Hydrocodone—Dizziness—Docetaxel—prostate cancer	4.9e-05	0.000352	CcSEcCtD
Hydrocodone—Thrombocytopenia—Epirubicin—prostate cancer	4.9e-05	0.000351	CcSEcCtD
Hydrocodone—Skin disorder—Epirubicin—prostate cancer	4.86e-05	0.000349	CcSEcCtD
Hydrocodone—Hyperhidrosis—Epirubicin—prostate cancer	4.83e-05	0.000347	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—prostate cancer	4.83e-05	0.000347	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—prostate cancer	4.83e-05	0.000347	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—prostate cancer	4.81e-05	0.000345	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.79e-05	0.000344	CcSEcCtD
Hydrocodone—Dizziness—Capecitabine—prostate cancer	4.75e-05	0.000341	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—prostate cancer	4.72e-05	0.000339	CcSEcCtD
Hydrocodone—Vomiting—Docetaxel—prostate cancer	4.71e-05	0.000338	CcSEcCtD
Hydrocodone—Hypersensitivity—Prednisone—prostate cancer	4.71e-05	0.000338	CcSEcCtD
Hydrocodone—Rash—Docetaxel—prostate cancer	4.67e-05	0.000336	CcSEcCtD
Hydrocodone—Hypotension—Epirubicin—prostate cancer	4.67e-05	0.000335	CcSEcCtD
Hydrocodone—Dermatitis—Docetaxel—prostate cancer	4.67e-05	0.000335	CcSEcCtD
Hydrocodone—Headache—Docetaxel—prostate cancer	4.64e-05	0.000333	CcSEcCtD
Hydrocodone—Asthenia—Prednisone—prostate cancer	4.59e-05	0.000329	CcSEcCtD
Hydrocodone—Vomiting—Capecitabine—prostate cancer	4.56e-05	0.000328	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.56e-05	0.000327	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—prostate cancer	4.54e-05	0.000326	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—prostate cancer	4.53e-05	0.000325	CcSEcCtD
Hydrocodone—Rash—Capecitabine—prostate cancer	4.53e-05	0.000325	CcSEcCtD
Hydrocodone—Pruritus—Prednisone—prostate cancer	4.52e-05	0.000325	CcSEcCtD
Hydrocodone—Insomnia—Epirubicin—prostate cancer	4.52e-05	0.000325	CcSEcCtD
Hydrocodone—Dermatitis—Capecitabine—prostate cancer	4.52e-05	0.000325	CcSEcCtD
Hydrocodone—Headache—Capecitabine—prostate cancer	4.5e-05	0.000323	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—prostate cancer	4.49e-05	0.000323	CcSEcCtD
Hydrocodone—Paraesthesia—Epirubicin—prostate cancer	4.49e-05	0.000322	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—prostate cancer	4.47e-05	0.000321	CcSEcCtD
Hydrocodone—Dyspnoea—Epirubicin—prostate cancer	4.46e-05	0.00032	CcSEcCtD
Hydrocodone—Somnolence—Epirubicin—prostate cancer	4.45e-05	0.000319	CcSEcCtD
Hydrocodone—Nausea—Docetaxel—prostate cancer	4.4e-05	0.000316	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—prostate cancer	4.32e-05	0.00031	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Epirubicin—prostate cancer	4.32e-05	0.00031	CcSEcCtD
Hydrocodone—Fatigue—Epirubicin—prostate cancer	4.31e-05	0.00031	CcSEcCtD
Hydrocodone—Constipation—Epirubicin—prostate cancer	4.28e-05	0.000307	CcSEcCtD
Hydrocodone—Nausea—Capecitabine—prostate cancer	4.26e-05	0.000306	CcSEcCtD
Hydrocodone—Dizziness—Prednisone—prostate cancer	4.23e-05	0.000304	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.22e-05	0.000303	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—prostate cancer	4.18e-05	0.0003	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—prostate cancer	4.15e-05	0.000298	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—prostate cancer	4.13e-05	0.000296	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—prostate cancer	4.11e-05	0.000295	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Epirubicin—prostate cancer	4.09e-05	0.000294	CcSEcCtD
Hydrocodone—Vomiting—Prednisone—prostate cancer	4.07e-05	0.000292	CcSEcCtD
Hydrocodone—Rash—Prednisone—prostate cancer	4.03e-05	0.000289	CcSEcCtD
Hydrocodone—Dermatitis—Prednisone—prostate cancer	4.03e-05	0.000289	CcSEcCtD
Hydrocodone—Headache—Prednisone—prostate cancer	4.01e-05	0.000288	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.99e-05	0.000287	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—prostate cancer	3.99e-05	0.000286	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—prostate cancer	3.96e-05	0.000284	CcSEcCtD
Hydrocodone—Abdominal pain—Epirubicin—prostate cancer	3.95e-05	0.000284	CcSEcCtD
Hydrocodone—Body temperature increased—Epirubicin—prostate cancer	3.95e-05	0.000284	CcSEcCtD
Hydrocodone—Nausea—Prednisone—prostate cancer	3.8e-05	0.000273	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—prostate cancer	3.78e-05	0.000272	CcSEcCtD
Hydrocodone—Hypersensitivity—Epirubicin—prostate cancer	3.68e-05	0.000264	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—prostate cancer	3.66e-05	0.000263	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—prostate cancer	3.66e-05	0.000263	CcSEcCtD
Hydrocodone—Asthenia—Epirubicin—prostate cancer	3.59e-05	0.000258	CcSEcCtD
Hydrocodone—Pruritus—Epirubicin—prostate cancer	3.54e-05	0.000254	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—prostate cancer	3.41e-05	0.000245	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—prostate cancer	3.32e-05	0.000238	CcSEcCtD
Hydrocodone—Dizziness—Epirubicin—prostate cancer	3.31e-05	0.000237	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—prostate cancer	3.27e-05	0.000235	CcSEcCtD
Hydrocodone—Vomiting—Epirubicin—prostate cancer	3.18e-05	0.000228	CcSEcCtD
Hydrocodone—Rash—Epirubicin—prostate cancer	3.15e-05	0.000226	CcSEcCtD
Hydrocodone—Dermatitis—Epirubicin—prostate cancer	3.15e-05	0.000226	CcSEcCtD
Hydrocodone—Headache—Epirubicin—prostate cancer	3.13e-05	0.000225	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—prostate cancer	3.06e-05	0.00022	CcSEcCtD
Hydrocodone—Nausea—Epirubicin—prostate cancer	2.97e-05	0.000213	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—prostate cancer	2.94e-05	0.000211	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—prostate cancer	2.92e-05	0.000209	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—prostate cancer	2.91e-05	0.000209	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—prostate cancer	2.9e-05	0.000208	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—prostate cancer	2.75e-05	0.000197	CcSEcCtD
Hydrocodone—OPRM1—Signaling Pathways—ERBB3—prostate cancer	6.46e-06	0.000116	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGFR2—prostate cancer	6.45e-06	0.000116	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF1—prostate cancer	6.44e-06	0.000116	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EGFR—prostate cancer	6.41e-06	0.000115	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—BAD—prostate cancer	6.37e-06	0.000115	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NCOA3—prostate cancer	6.3e-06	0.000113	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAP2K1—prostate cancer	6.22e-06	0.000112	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PHGDH—prostate cancer	6.22e-06	0.000112	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—UMPS—prostate cancer	6.22e-06	0.000112	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ARG2—prostate cancer	6.22e-06	0.000112	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL2—prostate cancer	6.21e-06	0.000112	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TERT—prostate cancer	6.19e-06	0.000111	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CD—prostate cancer	6.18e-06	0.000111	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APC—prostate cancer	6.17e-06	0.000111	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CG—prostate cancer	6.17e-06	0.000111	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CA—prostate cancer	6.13e-06	0.00011	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SERPINE1—prostate cancer	6.12e-06	0.00011	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGF—prostate cancer	6.1e-06	0.00011	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IRS1—prostate cancer	6.1e-06	0.00011	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LDHB—prostate cancer	6.1e-06	0.00011	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—KRAS—prostate cancer	6.05e-06	0.000109	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HPGDS—prostate cancer	6.01e-06	0.000108	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.98e-06	0.000108	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2C19—prostate cancer	5.97e-06	0.000107	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FGF2—prostate cancer	5.92e-06	0.000107	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GSK3B—prostate cancer	5.92e-06	0.000106	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HIF1A—prostate cancer	5.92e-06	0.000106	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOS3—prostate cancer	5.84e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—INS—prostate cancer	5.84e-06	0.000105	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ACHE—prostate cancer	5.83e-06	0.000105	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTT1—prostate cancer	5.83e-06	0.000105	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PDHA1—prostate cancer	5.78e-06	0.000104	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TCN2—prostate cancer	5.78e-06	0.000104	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA3—prostate cancer	5.78e-06	0.000104	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—UCP3—prostate cancer	5.78e-06	0.000104	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LEP—prostate cancer	5.78e-06	0.000104	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2A6—prostate cancer	5.76e-06	0.000104	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CAV1—prostate cancer	5.72e-06	0.000103	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CREBBP—prostate cancer	5.72e-06	0.000103	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—JAK2—prostate cancer	5.68e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KDR—prostate cancer	5.66e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF1—prostate cancer	5.65e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EGFR—prostate cancer	5.62e-06	0.000101	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKR1C3—prostate cancer	5.6e-06	0.000101	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PRKACB—prostate cancer	5.57e-06	0.0001	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CA—prostate cancer	5.56e-06	0.0001	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MDM2—prostate cancer	5.54e-06	9.96e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.52e-06	9.92e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ESR1—prostate cancer	5.51e-06	9.92e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.51e-06	9.92e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.51e-06	9.92e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ERBB2—prostate cancer	5.46e-06	9.82e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAP2K1—prostate cancer	5.46e-06	9.82e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CD—prostate cancer	5.42e-06	9.75e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CB—prostate cancer	5.39e-06	9.7e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—BAD—prostate cancer	5.38e-06	9.68e-05	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CA—prostate cancer	5.37e-06	9.66e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SERPINE1—prostate cancer	5.36e-06	9.65e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—KRAS—prostate cancer	5.31e-06	9.55e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA4—prostate cancer	5.29e-06	9.51e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.29e-06	9.51e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NCOA2—prostate cancer	5.26e-06	9.45e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CG—prostate cancer	5.21e-06	9.38e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APC—prostate cancer	5.21e-06	9.38e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGF2—prostate cancer	5.19e-06	9.34e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL8—prostate cancer	5.18e-06	9.32e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGF—prostate cancer	5.15e-06	9.27e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IRS1—prostate cancer	5.15e-06	9.27e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA2—prostate cancer	5.15e-06	9.26e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOS3—prostate cancer	5.12e-06	9.21e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCG5—prostate cancer	5.09e-06	9.15e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.09e-06	9.15e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1B—prostate cancer	5.06e-06	9.1e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.01e-06	9.02e-05	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT1—prostate cancer	5e-06	9e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GSK3B—prostate cancer	5e-06	9e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—JAK2—prostate cancer	4.98e-06	8.95e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA1—prostate cancer	4.97e-06	8.94e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CASP3—prostate cancer	4.96e-06	8.92e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL2—prostate cancer	4.95e-06	8.9e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—INS—prostate cancer	4.93e-06	8.88e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—prostate cancer	4.93e-06	8.86e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTO1—prostate cancer	4.91e-06	8.84e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.91e-06	8.84e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NAT2—prostate cancer	4.91e-06	8.84e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.9e-06	8.81e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CA—prostate cancer	4.88e-06	8.77e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MDM2—prostate cancer	4.86e-06	8.74e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NQO1—prostate cancer	4.84e-06	8.71e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CREBBP—prostate cancer	4.83e-06	8.69e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCND1—prostate cancer	4.83e-06	8.68e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ERBB2—prostate cancer	4.79e-06	8.61e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CTNNB1—prostate cancer	4.78e-06	8.6e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1—prostate cancer	4.77e-06	8.59e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TH—prostate cancer	4.77e-06	8.58e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EGFR—prostate cancer	4.75e-06	8.54e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CB—prostate cancer	4.73e-06	8.5e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.72e-06	8.49e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLCB2—prostate cancer	4.71e-06	8.47e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LRP2—prostate cancer	4.71e-06	8.47e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.71e-06	8.47e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—prostate cancer	4.68e-06	8.43e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1A—prostate cancer	4.67e-06	8.4e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTEN—prostate cancer	4.66e-06	8.38e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.64e-06	8.35e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—P4HB—prostate cancer	4.62e-06	8.31e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	4.61e-06	8.3e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	4.58e-06	8.24e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT1—prostate cancer	4.54e-06	8.17e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL8—prostate cancer	4.54e-06	8.17e-05	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	4.54e-06	8.16e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	4.53e-06	8.15e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GGT1—prostate cancer	4.5e-06	8.09e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.49e-06	8.08e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—KRAS—prostate cancer	4.49e-06	8.07e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EP300—prostate cancer	4.44e-06	7.99e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	4.44e-06	7.98e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NCOA1—prostate cancer	4.43e-06	7.97e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGF2—prostate cancer	4.39e-06	7.89e-05	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	4.39e-06	7.89e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.38e-06	7.88e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.37e-06	7.85e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CASP3—prostate cancer	4.35e-06	7.82e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL2—prostate cancer	4.34e-06	7.81e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOS3—prostate cancer	4.33e-06	7.78e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SRC—prostate cancer	4.32e-06	7.77e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—prostate cancer	4.32e-06	7.77e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MED12—prostate cancer	4.31e-06	7.75e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GNG5—prostate cancer	4.27e-06	7.69e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCND1—prostate cancer	4.23e-06	7.61e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—RXRA—prostate cancer	4.21e-06	7.58e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—prostate cancer	4.21e-06	7.57e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JAK2—prostate cancer	4.21e-06	7.57e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	4.19e-06	7.54e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT3—prostate cancer	4.17e-06	7.49e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	4.12e-06	7.41e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOA3—prostate cancer	4.12e-06	7.41e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—prostate cancer	4.11e-06	7.39e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MDM2—prostate cancer	4.11e-06	7.38e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	4.09e-06	7.36e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTEN—prostate cancer	4.08e-06	7.35e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—COMT—prostate cancer	4.06e-06	7.3e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ERBB2—prostate cancer	4.05e-06	7.28e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTP1—prostate cancer	4.04e-06	7.27e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	3.99e-06	7.18e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT1—prostate cancer	3.98e-06	7.17e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ITPR1—prostate cancer	3.97e-06	7.15e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HPGDS—prostate cancer	3.93e-06	7.07e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.9e-06	7.02e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EP300—prostate cancer	3.89e-06	7.01e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MYC—prostate cancer	3.87e-06	6.96e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—prostate cancer	3.86e-06	6.95e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL8—prostate cancer	3.84e-06	6.9e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTT1—prostate cancer	3.81e-06	6.85e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ACHE—prostate cancer	3.81e-06	6.85e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SRC—prostate cancer	3.79e-06	6.81e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGFR—prostate cancer	3.79e-06	6.81e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.77e-06	6.77e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TYMS—prostate cancer	3.75e-06	6.75e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	3.75e-06	6.74e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTM1—prostate cancer	3.71e-06	6.68e-05	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	3.71e-06	6.67e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—prostate cancer	3.69e-06	6.64e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CASP3—prostate cancer	3.67e-06	6.61e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2—prostate cancer	3.67e-06	6.6e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.66e-06	6.59e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT3—prostate cancer	3.65e-06	6.57e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—prostate cancer	3.65e-06	6.57e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PRKACB—prostate cancer	3.64e-06	6.55e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LPL—prostate cancer	3.64e-06	6.55e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.61e-06	6.49e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KRAS—prostate cancer	3.58e-06	6.43e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCND1—prostate cancer	3.58e-06	6.43e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	3.54e-06	6.37e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.52e-06	6.33e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ERCC2—prostate cancer	3.49e-06	6.28e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—prostate cancer	3.47e-06	6.25e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	3.46e-06	6.22e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTEN—prostate cancer	3.45e-06	6.21e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOA2—prostate cancer	3.44e-06	6.18e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MYC—prostate cancer	3.39e-06	6.1e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—prostate cancer	3.39e-06	6.09e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT1—prostate cancer	3.37e-06	6.06e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGFR—prostate cancer	3.32e-06	5.97e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EP300—prostate cancer	3.29e-06	5.92e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	3.29e-06	5.91e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—prostate cancer	3.28e-06	5.9e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.28e-06	5.9e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARA—prostate cancer	3.22e-06	5.79e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.2e-06	5.76e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SRC—prostate cancer	3.2e-06	5.76e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TP53—prostate cancer	3.18e-06	5.72e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NQO1—prostate cancer	3.17e-06	5.7e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KRAS—prostate cancer	3.14e-06	5.64e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TH—prostate cancer	3.12e-06	5.61e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—prostate cancer	3.12e-06	5.61e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT3—prostate cancer	3.09e-06	5.55e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.04e-06	5.46e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CAV1—prostate cancer	3.03e-06	5.44e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GGT1—prostate cancer	2.94e-06	5.29e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—prostate cancer	2.91e-06	5.23e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOA1—prostate cancer	2.9e-06	5.21e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	2.88e-06	5.18e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MYC—prostate cancer	2.87e-06	5.16e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—prostate cancer	2.86e-06	5.15e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.85e-06	5.13e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGFR—prostate cancer	2.81e-06	5.05e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TP53—prostate cancer	2.79e-06	5.01e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.76e-06	4.96e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—RXRA—prostate cancer	2.75e-06	4.95e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT1—prostate cancer	2.68e-06	4.83e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—COMT—prostate cancer	2.65e-06	4.77e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KRAS—prostate cancer	2.65e-06	4.77e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTP1—prostate cancer	2.64e-06	4.75e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—INS—prostate cancer	2.61e-06	4.69e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ITPR1—prostate cancer	2.6e-06	4.67e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CREBBP—prostate cancer	2.56e-06	4.6e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—prostate cancer	2.55e-06	4.59e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TYMS—prostate cancer	2.46e-06	4.42e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	2.44e-06	4.38e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM1—prostate cancer	2.43e-06	4.36e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.42e-06	4.36e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LPL—prostate cancer	2.38e-06	4.28e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TP53—prostate cancer	2.36e-06	4.24e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT1—prostate cancer	2.35e-06	4.23e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.3e-06	4.14e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NOS3—prostate cancer	2.29e-06	4.12e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ERCC2—prostate cancer	2.28e-06	4.1e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—prostate cancer	2.16e-06	3.88e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—prostate cancer	2.14e-06	3.86e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.11e-06	3.8e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARA—prostate cancer	2.1e-06	3.78e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS2—prostate cancer	2.09e-06	3.76e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT1—prostate cancer	1.99e-06	3.58e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CAV1—prostate cancer	1.98e-06	3.56e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTEN—prostate cancer	1.82e-06	3.28e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.8e-06	3.24e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—EP300—prostate cancer	1.74e-06	3.13e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—INS—prostate cancer	1.71e-06	3.07e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CREBBP—prostate cancer	1.67e-06	3.01e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.58e-06	2.85e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NOS3—prostate cancer	1.5e-06	2.69e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.38e-06	2.48e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS2—prostate cancer	1.37e-06	2.46e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.29e-06	2.32e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTEN—prostate cancer	1.19e-06	2.15e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—EP300—prostate cancer	1.14e-06	2.05e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKT1—prostate cancer	1.05e-06	1.89e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CA—prostate cancer	8.42e-07	1.51e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKT1—prostate cancer	6.88e-07	1.24e-05	CbGpPWpGaD
